WHITEHAWK THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable, Related Parties
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Increase (Decrease) in Accounts Payable, Related Parties of -$8.38 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2022-03-17
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2021-12-31 was $155.00K, a 94.23% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2020-12-31 was $2.69M.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts payable, related parties for fiscal 2021 was -$8.38M, a 440.51% decline from fiscal 2020.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts payable, related parties for fiscal 2020 was $2.46M.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month |
|---|---|---|---|
| 2021-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$8.38M 10-K · filed 2022-03-17 | |
| 2021-09-30 | -$8.54M 10-Q · filed 2021-11-10 | ||
| 2020-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $2.46M 10-K · filed 2022-03-17 | |
| 2020-09-30 | -$226.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |